CervoMed (CRVO) Return on Capital Employed [ROCE] (2009 - 2026)
CervoMed (CRVO) posted Return on Capital Employed [ROCE] of -128.10% for Q4 2025, down 84.80 percentage points from -43.29% a year earlier.
Powered by 
Analysis
CervoMed (CRVO) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends
For FY2025, CervoMed's Return on Capital Employed [ROCE] came in at -99.90%, down 19.42 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a five-year change of -31.87 percentage points (FY2020 to FY2025).
- In prior years, CervoMed's Return on Capital Employed [ROCE] was -80.48% in FY2024 and -82.65% in FY2021 (-14.63 pp).
- The Q4 2025 figure stands as the lowest quarterly Return on Capital Employed [ROCE] since Q2 2017.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2022, with a gain of 5.75 percentage points; the weakest was Q4 2025, with a drop of 84.80 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | CervoMed | 20.73 Mn | -57.60 Mn | - | -148.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -148.45% |
| Dec 31, 2025 | -128.10% |
| Dec 31, 2024 | -43.29% |
| Sep 30, 2022 | -51.68% |
| Jun 30, 2022 | -86.47% |
| Mar 31, 2022 | -74.95% |
| Dec 31, 2021 | -67.73% |
| Sep 30, 2021 | -57.44% |
| Jun 30, 2021 | -34.14% |
| Mar 31, 2021 | -44.42% |
| Dec 31, 2020 | -36.75% |
| Sep 30, 2020 | -28.58% |
| Jun 30, 2020 | -25.11% |
| Mar 31, 2020 | -26.66% |
| Dec 31, 2019 | -62.67% |
| Sep 30, 2019 | -86.56% |
| Jun 30, 2019 | -110.07% |
| Mar 31, 2019 | -116.51% |
| Dec 31, 2018 | -94.35% |
| Sep 30, 2018 | -61.40% |
API Access
CervoMed Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CRVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "CRVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CRVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();